Despite the positive effect of VEGF blockade on the vascular leakage and regression of neovascularisation, severe damage as seen in the development of geographic atrophy and poor vision has been observed in age-related macular degradation (AMD) patients after extended treatment with anti-VEGF antibodies [83]. This evidence concerns the gene VEGFA and atrophic macular degeneration.